Pharmaceutical

JURA Bio and Syena partner to develop TCR-based therapies

JURA Bio has entered into a research collaboration with Replay cell therapy product company Syena for the development of TCR based therapies.

Sep 23, 2023 - 20:00
JURA Bio and Syena partner to develop TCR-based therapies
JURA Bio has entered into a research collaboration with Replay cell therapy product company Syena for the development of TCR based therapies.
Read the original article

Tags:

Previous Article

Alvotech’s AVT05 in phase III rheumatoid arthritis study, as the sole candidate

Next Article

Signal: CMR Surgical Raises $165m to continue development of surgical robot

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

American Medical Association’s digital advisors table RPM coding reform proposal, again

American Medical Association’s digital advisors table R...

Feb 15, 2024

UK pharma group reprimands Novo Nordisk for undisclosed payments

UK pharma group reprimands Novo Nordisk for undisclosed...

Jul 10, 2024

White House ‘naloxone summit’ omitting prominent advocates for lower costs

White House ‘naloxone summit’ omitting prominent advoca...

Jun 16, 2023